Cargando…

Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review

Immunotherapy directed at the programmed cell death-1 receptor (PD-1) or its ligand PD-L1 has proven effective in solid malignancies such as melanoma, non-small cell lung cancer (NSCLC), urothelial cancer, renal cell carcinoma, and head and neck cancer. Compared with cytotoxic chemotherapy, radiothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cafaro, Alessandro, Bongiovanni, Alberto, Di Iorio, Valentina, Oboldi, Devil, Masini, Carla, Ibrahim, Toni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461970/ https://www.ncbi.nlm.nih.gov/pubmed/33014787 http://dx.doi.org/10.3389/fonc.2020.01478

Ejemplares similares

Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy
por: Recine, Federica, et al.
Publicado: (2022)

Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Editorial: New Insights Into the Landscape of Rare Tumors: Translational and Clinical Research Perspective
por: De Vita, Alessandro, et al.
Publicado: (2020)

Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review
por: FAROLFI, ALBERTO, et al.
Publicado: (2015)

The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure
por: Gasperoni, Lorenzo, et al.
Publicado: (2023)

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
por: Zibetti Dal Molin, Graziela, et al.
Publicado: (2018)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Molecular predictors of response to pembrolizumab in thymic carcinoma
por: He, Yongfeng, et al.
Publicado: (2021)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
por: Spathas, Nikolaos, et al.
Publicado: (2018)

Spindle Cell Squamous Cell Carcinoma of the Scalp Treated With Pembrolizumab Cisplatin and 5-Fluorouracil
por: Alzahrani, Ali M, et al.
Publicado: (2021)

A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
por: Hu, Nanlin, et al.
Publicado: (2021)

CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
por: Kashima, Jumpei, et al.
Publicado: (2022)

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c
por: Huang, Bei, et al.
Publicado: (2013)

Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis
por: Yang, Xudong, et al.
Publicado: (2020)

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review
por: Tan, Qiaoyun, et al.
Publicado: (2022)

Primary Hyperparathyroidism: Imaging to Pathology
por: Piciucchi, Sara, et al.
Publicado: (2012)

Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patients
por: Rossi, Alice, et al.
Publicado: (2023)

Real-World Experience with Pembrolizumab Treatment in Patients with Heavily Treated Recurrent Gynecologic Malignancies
por: Choi, Min Chul, et al.
Publicado: (2020)

Case Report: Opportunities and Challenges of Immunotherapy in Heavily-Treated EGFR-Mutant Advanced Squamous Cell Lung Carcinoma After Progression on EGFR-TKIs and Chemotherapy
por: Jin, Wei, et al.
Publicado: (2022)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Zeng, Tian, et al.
Publicado: (2021)

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2020)

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
por: Chahoud, Jad, et al.
Publicado: (2020)

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
por: Bocchini, Martine, et al.
Publicado: (2020)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

Thymic Carcinoma: A Review
por: Alqaidy, Doaa, et al.
Publicado: (2022)

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China
por: Yang, Wenyu, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for Patients with Heavily Pretreated Liver Metastases and Liver Tumors
por: Lanciano, Rachelle, et al.
Publicado: (2012)

Response to nab-paclitaxel and nedaplatin in a heavily-metastatic thymic carcinoma: A case report
por: ZHAN, PING, et al.
Publicado: (2015)

CT-Based Radiomics Nomogram for Differentiation of Anterior Mediastinal Thymic Cyst From Thymic Epithelial Tumor
por: Zhang, Chengzhou, et al.
Publicado: (2021)

Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin’s Lymphoma
por: Yu, Tsung-Ying, et al.
Publicado: (2020)

Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial
por: Sabatier, Renaud, et al.
Publicado: (2022)

An autopsy case of autoimmune meningoencephalitis caused by pembrolizumab
por: Hiraoka, Yuhi, et al.
Publicado: (2022)

Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015)

Imaging Evaluation of Thymoma and Thymic Carcinoma
por: Strange, Chad D., et al.
Publicado: (2022)

Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
por: Abid, Haisam, et al.
Publicado: (2019)

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
por: Wang, Jianglin, et al.
Publicado: (2023)

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma
por: Black, Christopher M., et al.
Publicado: (2023)

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary
por: Suzuki, Risako, et al.
Publicado: (2023)

Novel Biologic Therapies for Thymic Epithelial Tumors
por: Chen, Yuanbin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uofkiq9d7e35obie7o1t8bee4f